Cargando…
Immunoliposome co-delivery of bufalin and anti-CD40 antibody adjuvant induces synergetic therapeutic efficacy against melanoma
Liposomes constitute one of the most popular nanocarriers for improving the delivery and efficacy of agents in cancer patients. The purpose of this study was to design and evaluate immunoliposome co-delivery of bufalin and anti-CD40 to induce synergetic therapeutic efficacy while eliminating systemi...
Autores principales: | Li, Ying, Yuan, Jiani, Yang, Qian, Cao, Wei, Zhou, Xuanxuan, Xie, Yanhua, Tu, Honghai, Zhang, Ya, Wang, Siwang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260685/ https://www.ncbi.nlm.nih.gov/pubmed/25506218 http://dx.doi.org/10.2147/IJN.S73651 |
Ejemplares similares
-
Bufalin-Loaded PEGylated Liposomes: Antitumor Efficacy, Acute Toxicity, and Tissue Distribution
por: Yuan, Jiani, et al.
Publicado: (2019) -
Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes
por: Yuan, Jiani, et al.
Publicado: (2017) -
Bufalin induces mitochondrial dysfunction and promotes apoptosis of glioma cells by regulating Annexin A2 and DRP1 protein expression
por: Li, Yao, et al.
Publicado: (2021) -
Efficient targeted tumor imaging and secreted endostatin gene delivery by anti-CD105 immunoliposomes
por: Zhuo, Huiqin, et al.
Publicado: (2018) -
Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody
por: Saeed, Mesha, et al.
Publicado: (2016)